MA52220A - Composés hétérocycliques utilisés comme immunomodulateurs - Google Patents

Composés hétérocycliques utilisés comme immunomodulateurs

Info

Publication number
MA52220A
MA52220A MA052220A MA52220A MA52220A MA 52220 A MA52220 A MA 52220A MA 052220 A MA052220 A MA 052220A MA 52220 A MA52220 A MA 52220A MA 52220 A MA52220 A MA 52220A
Authority
MA
Morocco
Prior art keywords
immunomodulators
compounds used
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
MA052220A
Other languages
English (en)
Other versions
MA52220B1 (fr
Inventor
Jingwei Li
Liangxing Wu
Wenqing Yao
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Priority claimed from PCT/US2019/025036 external-priority patent/WO2019191707A1/fr
Publication of MA52220A publication Critical patent/MA52220A/fr
Publication of MA52220B1 publication Critical patent/MA52220B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA52220A 2018-03-30 2019-03-29 Composés hétérocycliques utilisés comme immunomodulateurs MA52220B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862650821P 2018-03-30 2018-03-30
PCT/US2019/025036 WO2019191707A1 (fr) 2018-03-30 2019-03-29 Composés hétérocycliques utilisés comme immunomodulateurs

Publications (2)

Publication Number Publication Date
MA52220A true MA52220A (fr) 2021-02-17
MA52220B1 MA52220B1 (fr) 2022-12-30

Family

ID=74446255

Family Applications (1)

Application Number Title Priority Date Filing Date
MA52220A MA52220B1 (fr) 2018-03-30 2019-03-29 Composés hétérocycliques utilisés comme immunomodulateurs

Country Status (2)

Country Link
AR (1) AR115314A1 (fr)
MA (1) MA52220B1 (fr)

Also Published As

Publication number Publication date
MA52220B1 (fr) 2022-12-30
AR115314A1 (es) 2020-12-23

Similar Documents

Publication Publication Date Title
MA46045A (fr) Composés hétérocycliques utilisés comme immunomodulateurs
MA45669A (fr) Composés hétérocycliques utilisés comme immunomodulateurs
MA44860A (fr) Composés hétérocycliques utilisés comme immunomodulateurs
FR24C1009I2 (fr) Composés utilisés comme inhibiteurs de kinase
MA52119A (fr) Composés hétérocycliques utilisés comme immunomodulateurs
MA45116A (fr) Composés hétérocycliques comme immunomodulateurs
DK4219492T3 (da) Heterocykliske forbindelser som immunmodulatorer
DK4212529T3 (da) Heterocykliske forbindelser som immunmodulatorer
EP3836923A4 (fr) Composés pyrrolo-dipyridine
EP3956033A4 (fr) Composés bicycliques
EP3402799A4 (fr) Composés hétérocycliques utilisés comme inhibiteurs du vrs
MA52948A (fr) Composés
MA55131A (fr) Nouveaux composés hétérocycliques
MA50609A (fr) Énantiomères de thiazoles substitués utilisés comme composés antiviraux
EP4061364A4 (fr) Composés hétéroaryles
MA51669A (fr) Composés
MA53003A (fr) Composés
MA43169A (fr) Composés hétérocycliques utilisés en tant qu'inhibiteurs de pi3k-gamma
MA51438A (fr) Composés hétérocycliques utilisés en tant qu'inhibiteurs de lsd1
MA50537A (fr) Composés deutérés utilisés comme immunomodulateurs
EP3666770A4 (fr) Nouveaux composés hétérocycliques comme inhibiteurs de cdk8/19
LT4101855T (lt) Priešnavikiniai junginiai
EP3319966A4 (fr) Composés hétérocycliques bicycliques utilisés comme inhibiteurs de pde2
EP3728289A4 (fr) Composés optimisés
EP4077318A4 (fr) Composés